Hyperuricemia in acute coronary syndrome and its relation with metabolic syndrome
DOI:
https://doi.org/10.55958/jcvd.v19i1.121Keywords:
Acute coronary syndrome, hyperuricemia, metabolic syndromeAbstract
INTRODUCTION: High mortality and morbidity are associated with coronary artery disease (CAD), the most common form of cardiovascular disease. In humans, uric acid is produced as a byproduct of purine decomposition. Numerous epidemiological studies have shown that high levels of blood uric acid are associated with an increased risk of ischemic heart disease and other cardiovascular disorders.
AIMS & OBJECTIVES: The objectives of the present study are: To determine frequency of hyperuricemia in acute coronary syndrome. To compare frequency of metabolic syndrome in patients of acute coronary syndrome with and without hyperuricemia.
MATERIAL & METHODS: It was a cross sectional study. Patients admitted with Acute Coronary Syndrome to the Punjab Institute of Cardiology Lahore between March 20 and September 20 of 2016 were included in this study. A total of 200 patients with Acute Coronary Syndrome who fulfilled the study's inclusion criteria and provided written informed consent were included. The demographic and clinical characteristics of each patient were recorded in the appropriate sections of the proforma, as required by the operational definition.
RESULTS: In our study, out of 200 cases of ACS, 26.5% were between 30-50 years of age while 73.5% were between 51-70 years. Mean age was calculated 54.24+8.91 years. There were 47.5% male and 52.5 females. Frequency of hyperuricemia in ACS was calculated as 29.5% and frequency of MetS in patients with ACS with and without hyperuricemia was recorded as 38.98% vs 19.15% with p value 0.003 showing a significant difference.
CONCLUSION: After analyzing data, we came to the conclusion that the prevalence of hyperuricemia is much greater in patients presenting with acute coronary syndrome, whereas the prevalence of metabolic syndrome is markedly higher in hyperuricemic cases compared to those without hyperuricemia.
KEYWORDS: Acute coronary syndrome, hyperuricemia, metabolic syndrome
References
Davidson S. Gout. In: Colledge NR, Walker BR, Ralston SH. Davidson’s principles and practice of medicine. 21st edition. India: Elsevier;2010:1097-98.
Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. ClinChimActa. 2008 Jun;392(1-2): 1-7 [cited on 30 september 2015] www.ncbi.nlm.nih.gov/pubmed/18348869.
Li-ying C, Wen-hua Z, Zhou-wen C, Hong-lei D, Jing-jing R, Jian-hua C. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang UnivSci B. 2007;8(8):593-98.
Bhalli MS, Kayani AM, Samore NA. Frequency of risk factors in male patients with acute coronary Syndrome. J CollPhysSurg Pak 2011;21 (5):271-75
Noor L, Adnan Y, Khan SB, Rehman UH, Ahmad F, Hafizullah M. Changing trend of presentation of acute coronary syndrome in Peshawar over the last sixteen years. J Ayub Med Coll 2011;23(2):136-39.
Torpy JM, Burke AE, Glass RM. Coronary Heart Disease Risk Factors. JAMA 2009;302(21):2388
Majeed MZ, Saeed M, Majid A, Manzur A. Association of hyperuricemia with acute coronary syndrome . JSZMC. 2014;5(3):674-76.
Abdullah AS, Begum N, Khan MAH, Hossain M, Kabir SMEJ, Alam MS. Admission serum uric acid levels and in-hospital outcomes in patients with acute coronary syndrome. J Enam Med Col. 2015;5 (1):15-22.
Abrar A, Khan S, Rehman A, Rehman MU, Jan T. Angiographic severity of coronary artery disease in patients with metabolic syndrome. Gomal Journal of Medical Sciences .2011;9(2):194-97.
Yasmin S, Mallick NH, Naveed T, Ali M, Noman A, Shakoor T. Metabolic syndrome in patients with ischemic heart disease. J Coll Physicians Surg Pak. 2008;18:605-7.
Brodov Y, Behar S, Boyko V, Chouraqui P. Effect of metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease ( from the bezafibrate infarction prevention study ) . Am J cardiol. 2010;106 (12):1717–20.
Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med. 1999;131:7-13.
Choi HK, Ford ES. Prevalence of metabolic syndrome in individuals with hyperuricemia. The American Journal of Medicine. 2007;120(5):442- 47.
Chuang S-Y, Chen J-H, Yeh W-T, Wu C-C, Pan W-H. Hyperuricemia and increased risk of ischemic heart disease in large Chinese cohort. International Journal of cardiology. 2012;154(3):316-21
